Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242115830 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Bianca Costa Soares de Sá und 7 weiteren Autor:innen. Beteiligte Einrichtung: Skin Cancer Department, A.C. Camargo Cancer Center, São Paulo 01529-001, Brazil. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundo de Apoio à Dermatologia do Estado de São Paulo - Sebastião Sampaio, Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Increased genetic risk for melanoma can occur in the context of germline pathogenic variants in high-penetrance genes, such as CDKN2A and CDK4, risk variants in low- to moderate-penetrance genes (MC1R and MITF), and possibly due to variants in emerging genes, such as ACD, TERF2IP, and TERT. We aimed to identify germline variants in high- and low- to moderate-penetrance melanoma risk genes in Brazilian patients with clinical criteria for familial melanoma syndrome. We selected patients with three or more melanomas or melanoma patients from families with three tumors (melanoma and pancreatic cancer) in first- or second-degree relatives. Genetic testing was performed with a nine-gene panel (ACD, BAP1, CDK4, CDKN2A, POT1, TERT, TERF2IP, MC1R, and MITF). In 36 patients, we identified 2 (5.6%) with germline pathogenic variants in CDKN2A and BAP1 and 4 (11.1%) with variants of uncertain significance in the high-penetrance genes. MC1R variants were found in 86.5%, and both red hair color variants and unknown risk variants were enriched in patients compared to a control group. The low frequency of germline pathogenic variants in the high-penetrance genes and the high prevalence of MC1R variants found in our cohort show the importance of the MC1R genotype in determining the risk of melanoma in the Brazilian melanoma-prone families.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Skin Cancer Department, A.C. Camargo Cancer Center, São Paulo 01529-001, Brazil.
- Clinical and Functional Genomics Group, International Research Center/CIPE, A.C. Camargo Cancer Center, 440 Taguá St., São Paulo 01508-010, Brazil.
- National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, 440 Taguá St., São Paulo 01508-010, Brazil.
- Oncogenetics Department, A.C. Camargo Cancer Center, São Paulo 01509-900, Brazil.
ORCID-Profile: Giovana Tardin Torrezan, João Pereira Duprat
Förderung
- Fundo de Apoio à Dermatologia do Estado de São Paulo - Sebastião Sampaio
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- CAPES
- Fundo de Apoio à Dermatologia do Estado de São Paulo—Sebastião Sampaio
Zitieren
APA
Soares de Sá, B. C., Moredo, L. F., Torrezan, G. T., Fidalgo, F., de Araújo, É. S. S., Formiga, M. N., Duprat, J. P., & Carraro, D. M. (2023). Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115830
Vancouver
Soares de Sá BC, Moredo LF, Torrezan GT, Fidalgo F, de Araújo ÉSS, Formiga MN, et al. Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115830
BibTeX
@article{SoaresdeS2023,
author = {Soares de Sá, Bianca Costa and Moredo, Luciana Facure and Torrezan, Giovana Tardin and Fidalgo, Felipe and de Araújo, Érica Sara Souza and Formiga, Maria Nirvana and Duprat, João Pereira and Carraro, Dirce Maria},
title = {Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242115830}
}
EUVIMED